| Literature DB >> 34214729 |
Abolfazl Akbari1, Meghdad Sedaghat2, Javad Heshmati3, Seidamir Pasha Tabaeian4, Sadegh Dehghani5, Ana Beatriz Pizarro6, Zahra Rostami7, Shahram Agah8.
Abstract
Curcumin is a bioactive ingredient found in the Rhizomes of Curcuma longa. Curcumin is well known for its chemopreventive and anti-cancer properties. Recent findings have demonstrated several pharmacological and biological impacts of curcumin, related to the control and the management of gastrointestinal cancers. Mechanistically, curcumin exerts its biological impacts via antioxidant and anti-inflammatory effects through the interaction with various transcription factors and signaling molecules. Moreover, epigenetic modulators such as microRNAs (miRNAs) have been revealed as novel targets of curcumin. Curcumin was discovered to regulate the expression of numerous pathogenic miRNAs in gastric, colorectal, esophageal and liver cancers. The present systematic review was performed to identify miRNAs that are modulated by curcumin in gastrointestinal cancers.Entities:
Keywords: Curcumin; Epigenetics; Gastrointestinal cancers; MicroRNA; Turmeric
Mesh:
Substances:
Year: 2021 PMID: 34214729 DOI: 10.1016/j.biopha.2021.111849
Source DB: PubMed Journal: Biomed Pharmacother ISSN: 0753-3322 Impact factor: 6.529